These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12690223

  • 41. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
    Huang Y, Gu S, Han Z, Yang Z, Zhong L, Li L, Wang R, Yan F, Luo Y, Borlongan C, Lu J.
    J Am Heart Assoc; 2023 Sep 05; 12(17):e029817. PubMed ID: 37655472
    [Abstract] [Full Text] [Related]

  • 42. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R, Xiao AY, Liu S, Wang M, Li G.
    Stroke; 2018 Jul 05; 49(7):1708-1718. PubMed ID: 29844028
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W, Li N, Gao D, Zhen H, Zhang X, Li F.
    J Vasc Surg; 2008 Sep 05; 48(3):709-14. PubMed ID: 18572362
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
    Xu J, Culman J, Blume A, Brecht S, Gohlke P.
    Stroke; 2003 May 05; 34(5):1287-92. PubMed ID: 12677021
    [Abstract] [Full Text] [Related]

  • 47. Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion.
    Lavallée PC, Mazighi M, Saint-Maurice JP, Meseguer E, Abboud H, Klein IF, Houdart E, Amarenco P.
    Stroke; 2007 Aug 05; 38(8):2270-4. PubMed ID: 17600235
    [Abstract] [Full Text] [Related]

  • 48. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M, Alvarez-Sabín J, Ribo M, Montaner J, Santamarina E, Arenillas JF, Huertas R, Delgado P, Purroy F, Molina CA.
    Stroke; 2005 Jul 05; 36(7):1452-6. PubMed ID: 15947260
    [Abstract] [Full Text] [Related]

  • 49. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC, Gasche Y.
    Brain Res; 2008 Dec 03; 1243():161-6. PubMed ID: 18835259
    [Abstract] [Full Text] [Related]

  • 50. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M, Alonso A, Hennerici MG, Fatar M.
    Int J Stroke; 2013 Oct 03; 8(7):496-502. PubMed ID: 22340025
    [Abstract] [Full Text] [Related]

  • 51. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY, Chung JI, Jalin AMA, Ju C, Pahk K, Joung C, Lee S, Jin S, Kim BS, Lee KS, Ryu JM, Kim WK.
    Int J Mol Sci; 2022 Jan 26; 23(3):. PubMed ID: 35163322
    [Abstract] [Full Text] [Related]

  • 52. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 26; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 53. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M, Polianski V, Nimrod A, Higazi A, Leker RR, Lamensdorf I.
    Neurol Res; 2011 Nov 26; 33(9):983-90. PubMed ID: 22081002
    [Abstract] [Full Text] [Related]

  • 54. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP.
    J Stroke Cerebrovasc Dis; 2016 Apr 26; 25(4):990-7. PubMed ID: 26851971
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.
    Circulation; 2005 Nov 29; 112(22):3486-94. PubMed ID: 16316970
    [Abstract] [Full Text] [Related]

  • 57. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
    Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B.
    Stroke; 1999 Dec 29; 30(12):2704-12; discussion 2712. PubMed ID: 10583001
    [Abstract] [Full Text] [Related]

  • 58. Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model.
    Paliwal P, Chauhan G, Gautam D, Dash D, Patne SCU, Krishnamurthy S.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun 29; 391(6):613-625. PubMed ID: 29602953
    [Abstract] [Full Text] [Related]

  • 59. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L, Zhang ZG, Zhang RL, Lu M, Adams J, Elliott PJ, Chopp M.
    Stroke; 2001 Dec 01; 32(12):2926-31. PubMed ID: 11739997
    [Abstract] [Full Text] [Related]

  • 60. Mechanistic insight into neurotoxicity of tissue plasminogen activator-induced thrombolysis products in a rat intraluminal middle cerebral artery occlusion model.
    Oka F, Fujisawa H, Nomura S, Kajiwara K, Kato S, Fujii M, Izuma H, Uozumi K, Gondo T, Suzuki M.
    J Neurotrauma; 2009 Sep 01; 26(9):1577-84. PubMed ID: 19275467
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.